在癌症中miR-1-3p的重要作用
Shangming Dai1,2, Fengjiao Li1,2, Shuoguo Xu1,2
1Department of Pharmacy, School of Pharmacy, Phase I Clinical Trial Centre, The Affiliated Changsha Central Hospital, Hengyang Medical School, University of South China, Changsha, China.
Journal of translational medicine
|November 1, 2023
概括
像miR-1-3p这样的微RNA (miRNA) 在癌症的发展和耐药性方面至关重要. 了解它们的分子机制对于改善癌症治疗结果至关重要.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 是一个遗传学.
背景情况:
- 癌症仍然是一个重大的全球健康威胁,复杂的机制驱动其进展和治疗抵抗力.
- 微RNAs (miRNAs) 是基因表达的关键调节者,影响各种生物过程,包括瘤发生.
- 一种特定的miRNAMiR-1-3p已经成为各种癌症的发展和进展中的关键参与者.
研究的目的:
- 为提供miR-1-3p在癌症中的作用的全面概述.
- 探索 miR-1-3p 参与瘤发生,发展和耐药性的分子机制.
- 讨论瘤学中miR-1-3p的临床意义和治疗向策略.
主要方法:
- 文献综述和对miR-1-3p.p.现有研究的综合.
- 在癌症模型中分析miR-1-3p的生物发生,调节和功能.
- 检查研究研究miR-1-3p与瘤发育,临床结果和治疗反应的关联.
主要成果:
- 在许多瘤类型中,MiR-1-3p经常受到调节失调,影响癌细胞的增殖,迁移和入侵.
- 异常表达miR-1-3p与瘤进展和对常规癌症疗法的耐药性相关.
- 向miR-1-3p为克服耐药性和改善患者预后提供了潜在的治疗策略.
结论:
- MiR-1-3p在癌症中发挥着多方面的作用,作为瘤发病,进展和治疗反应的关键调节者.
- 对miR-1-3p精确分子通路的进一步研究对于开发有效的基于miRNA的癌症疗法至关重要.
- 了解miR-1-3p的功能为瘤学中的诊断和治疗干预提供了新的途径.
相关概念视频
MicroRNAs
3.0K
MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K
Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
mTOR Signaling and Cancer Progression
3.8K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.8K
Induced Pluripotent Stem Cells
4.1K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.1K
Mitogens and the Cell Cycle
6.5K
Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.5K
Metastasis
5.6K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.6K


